S&P 500   2,746.90 (+3.29%)
DOW   23,386.11 (+3.23%)
QQQ   200.41 (+2.04%)
AAPL   265.69 (+2.41%)
FB   173.83 (+2.96%)
MSFT   165.38 (+1.16%)
GOOGL   1,209.87 (+2.31%)
AMZN   2,037.00 (+1.26%)
CGC   14.96 (+3.24%)
NVDA   266.75 (+2.98%)
BABA   195.10 (-1.46%)
MU   48.48 (+4.17%)
GE   7.30 (+3.84%)
TSLA   546.44 (+0.18%)
AMD   48.83 (+2.67%)
T   29.72 (-1.20%)
ACB   0.86 (+7.50%)
F   5.03 (+6.80%)
BAC   23.36 (+5.51%)
GILD   74.67 (+0.00%)
DIS   100.52 (-0.71%)
PRI   97.04 (+10.20%)
S&P 500   2,746.90 (+3.29%)
DOW   23,386.11 (+3.23%)
QQQ   200.41 (+2.04%)
AAPL   265.69 (+2.41%)
FB   173.83 (+2.96%)
MSFT   165.38 (+1.16%)
GOOGL   1,209.87 (+2.31%)
AMZN   2,037.00 (+1.26%)
CGC   14.96 (+3.24%)
NVDA   266.75 (+2.98%)
BABA   195.10 (-1.46%)
MU   48.48 (+4.17%)
GE   7.30 (+3.84%)
TSLA   546.44 (+0.18%)
AMD   48.83 (+2.67%)
T   29.72 (-1.20%)
ACB   0.86 (+7.50%)
F   5.03 (+6.80%)
BAC   23.36 (+5.51%)
GILD   74.67 (+0.00%)
DIS   100.52 (-0.71%)
PRI   97.04 (+10.20%)
S&P 500   2,746.90 (+3.29%)
DOW   23,386.11 (+3.23%)
QQQ   200.41 (+2.04%)
AAPL   265.69 (+2.41%)
FB   173.83 (+2.96%)
MSFT   165.38 (+1.16%)
GOOGL   1,209.87 (+2.31%)
AMZN   2,037.00 (+1.26%)
CGC   14.96 (+3.24%)
NVDA   266.75 (+2.98%)
BABA   195.10 (-1.46%)
MU   48.48 (+4.17%)
GE   7.30 (+3.84%)
TSLA   546.44 (+0.18%)
AMD   48.83 (+2.67%)
T   29.72 (-1.20%)
ACB   0.86 (+7.50%)
F   5.03 (+6.80%)
BAC   23.36 (+5.51%)
GILD   74.67 (+0.00%)
DIS   100.52 (-0.71%)
PRI   97.04 (+10.20%)
S&P 500   2,746.90 (+3.29%)
DOW   23,386.11 (+3.23%)
QQQ   200.41 (+2.04%)
AAPL   265.69 (+2.41%)
FB   173.83 (+2.96%)
MSFT   165.38 (+1.16%)
GOOGL   1,209.87 (+2.31%)
AMZN   2,037.00 (+1.26%)
CGC   14.96 (+3.24%)
NVDA   266.75 (+2.98%)
BABA   195.10 (-1.46%)
MU   48.48 (+4.17%)
GE   7.30 (+3.84%)
TSLA   546.44 (+0.18%)
AMD   48.83 (+2.67%)
T   29.72 (-1.20%)
ACB   0.86 (+7.50%)
F   5.03 (+6.80%)
BAC   23.36 (+5.51%)
GILD   74.67 (+0.00%)
DIS   100.52 (-0.71%)
PRI   97.04 (+10.20%)
Log in

Compare Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).
Date Range: 

 Denali TherapeuticsAlectorFate TherapeuticsBill.comRegenxbio
SymbolNASDAQ:DNLINASDAQ:ALECNASDAQ:FATENASDAQ:RVMDNASDAQ:RGNX
Price Information
Current Price$18.60$23.73$25.46$23.02$31.36
52 Week RangeBuyBuyBuyBuyBuy
Analyst Ratings
Consensus RecommendationBuyBuyBuyBuyBuy
Consensus Price Target$29.67$28.00$35.44$41.00$76.75
% Upside from Price Target59.50% upside17.99% upside39.19% upside78.11% upside144.74% upside
Trade Information
Market Cap$1.91 billion$1.85 billion$1.74 billion$1.40 billion$1.15 billion
Beta1.81.241.8N/A1.04
Average Volume741,010651,6201,170,019489,311535,176
Sales & Book Value
Annual Revenue$26.68 million$21.22 million$10.68 millionN/A$35.23 million
Price / Sales73.5087.81181.03N/A33.06
CashflowN/AN/AN/AN/AN/A
Price / CashN/AN/AN/AN/AN/A
Book Value$4.11 per share$2.83 per share$3.24 per shareN/A$12.23 per share
Price / Book4.538.397.86N/A2.56
Profitability
Net Income$-197,610,000.00$-105,390,000.00$-98,150,000.00N/A$-94,730,000.00
EPS($2.07)($1.71)($1.44)N/A($3.26)
Trailing P/E RatioN/AN/AN/A0.00N/A
Forward P/E RatioN/AN/AN/AN/AN/A
P/E GrowthN/AN/AN/AN/AN/A
Net Margins-740.74%-496.65%-919.00%N/A-268.88%
Return on Equity (ROE)-43.31%-45.56%-49.94%N/A-25.21%
Return on Assets (ROA)-32.00%-22.85%-36.92%N/A-23.31%
Dividend
Annual PayoutN/AN/AN/AN/AN/A
Dividend YieldN/AN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity Ratio0.17%0.21%0.10%N/A0.02%
Current Ratio9.48%5.77%8.17%N/A10.25%
Quick Ratio9.48%5.77%8.17%N/A10.25%
Ownership Information
Institutional Ownership Percentage67.08%53.54%95.07%N/A80.84%
Insider Ownership Percentage21.20%13.90%21.41%N/A13.80%
Miscellaneous
Employees17991104N/A192
Shares Outstanding105.42 million78.53 million75.94 million59.00 million37.14 million
Next Earnings Date5/13/2020 (Estimated)5/11/2020 (Estimated)5/5/2020 (Estimated)N/A5/5/2020 (Estimated)
OptionableOptionableNot OptionableOptionableNot OptionableOptionable

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel